Free Trial
CVE:IAN

iAnthus Capital (IAN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IAN stock logo

About iAnthus Capital Stock (CVE:IAN)

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 31 dispensaries and 10 cultivation and/or processing facilities in 9 states. The company is headquartered in New York, New York.

IAN Stock News Headlines

Massive shakeup in defense contracting
There is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.
iAnthus Capital Holdings Inc.
Timeless Vapes Enters New Jersey Cannabis Market
Massive shakeup in defense contracting
There is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.
iAnthus Announces Results from Annual General Meeting
See More Headlines
Receive IAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iAnthus Capital and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
9/16/2024
Next Earnings (Estimated)
11/14/2024

Industry, Sector and Symbol

Industry
Agricultural Production – Crops
Sub-Industry
Agriculture
CIK
N/A
Web
N/A
Fax
N/A
Employees
1,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

IAN Stock Analysis - Frequently Asked Questions

How do I buy shares of iAnthus Capital?

Shares of IAN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of iAnthus Capital own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iAnthus Capital investors own include Aphria (APHA), MPX International (MPXOF), Emerald Health Therapeutics (EMH), Organigram (OGI), HEXO (HEXO), Netflix (NFLX) and Albemarle (ALB).

This page (CVE:IAN) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners